The complexity and novelty of public health genomics poses a challenge to ensure effective and responsible translation of genome-based information for the benefit of population health. The aim of this article is to provide literature-based insight into how the concept of health literacy can act as a catalyst for the translation process and to comment on the necessity to adapt new perspectives in a rapidly changing world, such as e.g. the health literacy-friendly approach of Google. Taking advantage of the potential of health literacy in the population along with a recognized role of health professionals as knowledge brokers and ‘nudges’ will benefit the efficiency and responsibility of translating genome-based knowledge.

1.
Johnson JD, Case DO, Andrews JE, Allard SL: Genomics – the perfect information-seeking research problem. J Health Commun 2005;10:323–329.
2.
Burke W, Khoury MJ, Stewart A, Zimmern R, Bellagio Group: The path from genome-based research to population health: development of an international public health genomics network. Genet Med 2006;8:451–458.
3.
Institute of Medicine: Health Literacy: A Prescription to End Confusion. Washington, The National Academies Press, 2004.
4.
Brand H, Brand A: Public Health Genomics. The integration of genome-based knowledge into public health research, policies and health services (in German). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007;50:135–144.
5.
Nutbeam D: Health promotion glossary. Health Promot Int 1998;13:349–364.
6.
Sorensen K on behalf of the HLS-EU Consortium: Measuring health literacy in Europe in the view of the European Health Literacy Survey. G46. 3rd European Public Health Conference, 10–13 November 2010, Amsterdam, The Netherlands.
7.
Freedman DA, Bess KD, Tucker HA, Boyd DL, Tuchman AM, Wallston KA: Public health literacy defined. Am J Prev Med 2009;36:446–451.
8.
Wade CH, McBride CM, Kardia SLR, Brody LC: Considerations for designing a prototype genetic test for use in translational research. Public Health Genomics 2010;13:155–165.
9.
Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, Bradley L: The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med 2007;9:665–674.
10.
Lenfant C: Clinical research to clinical practice – lost in translation? N Engl J Med 2003;349:868–874.
11.
Gazmararian JA, Curran JW, Parker RM, Bernhardt JM, DeBuona DA: Public health literacy in America: an ethical imperative. Am J Prev Med 2005;28:317–322.
12.
Jarvis J: What Would Google Do? New York, Harper, 2009.
13.
Kickbusch IS, Maag D: Health literacy: towards active health citizenship; in Sprenger M (ed):Public Health in Oesterreich und Europa. Graz, Festschrift Horst Noack, 2006.
14.
Simonds SK: Health education as social policy. Health Educ Monogr 1974;2:1–25.
15.
Berkman ND, deWalt DA, Pignone MP, Sheridan SL, Lohr KN, Lux L, Sutton SF, Swinson T, Bonito AJ: Literacy and health outcomes. Rockwille, Agency for Healthcare Research and Quality, 2004.
16.
US Department of Health and Human Services, Office of Disease Prevention and Health Promotion: National Action Plan to Improve Health Literacy. Washington, US Department of Health and Human Services, 2010.
17.
Nutbeam D: Health literacy as a public goal: a challenge for contemporary health education and communication strategies into the 21st century. Health Promot Int 2000;15:259–267.
18.
Apter AJ, Paasche-Orlow MK, Remillard JT, Benett IM, Ben-Josep EP, Batista RM, Hyde J, Rudd RE: Numeracy and communication with patients: they are counting on us.J Gen Intern Med 2008;23:2117–2124.
19.
Cutilli, C: Seeking health information: what sources do your patients use? Orthop Nurs 2010;29:214–219.
20.
Longo DR: Understanding health information, communication, and information seeking of patients and consumers: a comprehensive and integrated model. Health Expect 2005;8:189–194.
21.
de Haes H: Dilemmas in patient centeredness and shared decision making: a case for vulnerability. Patient Educ Couns 2006;62:291–298.
22.
Peerson A, Saunders M: Health literacy revisited: what do we mean and why does it matter? Health Promot Int 2009;24:285–296.
23.
Collins English Dictionary – Complete and Unabridged. London, HarperCollins, 2003.
24.
Thaler R, Sunstein C: Nudge: Improving Decisions about Health, Wealth and Happiness. Suffolk, Penguin Books, 2009.
25.
Boccia S, Brand A, Brand H, Ricciardi G: The integration of genome-based information for common diseases into health policy and healthcare as a major challenge for public health genomics: the example of the methylenetetrahydrofolate reductase gene in non-cancer diseases. Mutat Res 2009;667:27–34.
26.
Khoury MJ: Dealing with the evidence dilemma in genomics and personalized medicine. Clin Pharmacol Ther 2010;87:635–638.
27.
Bubela T: Science communication in transition: genomics hype, public engagement, education and commercialization pressures. Clin Genet 2006;70:445–450.
28.
Rosenkoetter N, Vondeling H, Blancquart I, Mekel OCL, Kristensen FB, Brand A: The contribution of health technology assessment, health needs assessment, and health impact assessment to the assessment and translation of technologies in the field of public health genomics. Public Health Genomics 2011;14:43–52.
29.
Burton H, Adams M, Bunton R, Schroeder-Beck P: Developing stakeholder involvement for introducing public health genomics into public policy. Public Health Genomics 2009;12:11–19.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.